Table 3. Mean ERP amplitudes (μV) for ADHD patients (n = 33) and healthy controls (n = 31).
ADHD | Control | ADHD | Control | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Relevant trials | Irrelevant trials | |||||||||||
Mean | SD | 95% CI | Mean | SD | 95% CI | Mean | SD | 95% CI | Mean | SD | 95% CI | |
Cue P3 Go | ||||||||||||
Cz | 0.2 | 1.0 | 0.23[-0.11–0.57] | 0.4 | 1.1 | 0.39[-0.00–0.80] | -0.1 | 0.7 | -0.13[-0.36–0.16] | 0.0 | 1.1 | -0.03[-0.35–0.45] |
Pz | 2.2 | 1.3 | 2.19 [1.79–2.70] | 2.6 | 0.9 | 2.62[2.29–2.98] | 0.9 | 0.8 | 0.94[0.61–1.21] | 1.1 | 0.7 | 1.05[0.81–1.34] |
Late CNV | ||||||||||||
Fz | 0.2 | 1.5 | 0.14[-0.37–0.71] | 0.3 | 1.1 | 0.1[2–0.25–0.79] | 0.3 | 0.9 | 0.31[-0.00–0.61] | 0.5 | 1.1 | 0.46[0.14–0.96] |
Cz | -1.5 | 1.3 | -1.44[1.93–- 1.04] | -1.8 | 1.1 | -1.76[-2.14–-1.37] | 0.0 | 0.8 | 0.03[-0.24–0.31] | -0.1 | 0.8 | -0.15[-0.41–0.21] |
Pz | -1.5 | 0.9 | -1.45[-1.81–-1.19] | -1.6 | 1.0 | -1.52[-1.92–-1.18] | -0.2 | 0.7 | -0.18[-0.48–0.02] | -0.5 | 0.8 | -0.49[-0.79–-0.19] |
P3 Go | ||||||||||||
Cz | 4.0 | 2.2 | 3.96[3.09–4.74] | 5.6 | 2.5 | 5.43[4.63–6.48] | ||||||
Pz | 5.7 | 2.0 | 5.89[5.02–6.46] | 6.1 | 2.3 | 5.89[5.30–6.96] | ||||||
N2 NoGo | ||||||||||||
Fz | -2.9 | 3.1 | -2.90[-3.98–-1.76] | -3.1 | 3.1 | -3.06[-4.27–-1.98] | ||||||
Cz | 0.8 | 3.0 | 0.64[-0.28–1.82] | 1.0 | 2.0 | 0.94[0.28–1.76] | ||||||
P3 NoGo | ||||||||||||
Fz | 1.6 | 2.3 | 1.46[0.75–2.38] | 1.7 | 2.8 | 1.82[0.70–2.76] | ||||||
Cz | 4.5 | 2.4 | 4.39[3.59–5.31] | 6.5 | 3.2 | 6.34[5.30–7.64] | ||||||
Pz | 3.3 | 2.0 | 3.19[2.56–3.98] | 4.1 | 2.1 | 4.04[3.30–4.89] |